Ramipril provides better outcomes for unselected patients after an acute myocardial infarction than do other angiotensin converting-enzyme (ACE) inhibitors, according to a report in the November 15th American Journal of Cardiology.
Ramipril has been shown to reduce the risk of acute MI in patients with atherosclerosis, the authors explain, and ACE inhibitors have been shown in recent trials to lower mortality after acute MI.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!